Cerus Corporation
CERS
#7228
Rank
C$0.71 B
Marketcap
C$3.59
Share price
-0.77%
Change (1 day)
78.78%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.54 Million, an increase over its 2023 earnings that were of -C$40.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-38.08%
2024 -C$16.54 Million-58.95%
2023 -C$40.29 Million-20.74%
2022 -C$50.83 Million-25.7%
2021 -C$68.41 Million-11.99%
2020 -C$77.73 Million-14%
2019 -C$90.39 Million21.73%
2018 -C$74.25 Million-0.65%
2017 -C$74.74 Million-10.96%
2016 -C$83.94 Million4.24%
2015 -C$80.53 Million50.99%
2014 -C$53.34 Million-10.08%
2013 -C$59.32 Million184.13%
2012 -C$20.88 Million-7.91%
2011 -C$22.67 Million
2009 -C$32.02 Million-24.69%
2008 -C$42.51 Million-25.2%
2007 -C$56.83 Million330.54%
2006 -C$13.2 Million1.49%
2005 -C$13.01 Million-61.02%
2004 -C$33.37 Million
2002 -C$82.54 Million10.02%
2001 -C$75.02 Million34.25%
2000 -C$55.88 Million61.02%
1999 -C$34.71 Million-18.81%
1998 -C$42.75 Million93.08%
1997 -C$22.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.20 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.35 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.34 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.22 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA